- News & Features
The study relied on a “really carefully thought out” enzyme-linked immunosorbent assay (ELISA) test to detect drug levels in breast milk.
Are most people with osteoarthritis able to maintain a level of activity that will improve their condition? A new study says yes.
“The field of spondyloarthritis treatment is going through the same excitement and expansion that rheumatoid arthritis treatment went through 10 years ago,” said Dr. Atul Deodhar.
In his talk at ACR 2016, Dr. Joshua Korzenik addressed where IBD and rheumatology overlap, and where health care providers working in the two fields can teach one another.
The presence of the antibody rheumatoid factor in seemingly healthy men could have a negative effect on their bone density.
Researchers looked at whether ACPA, or rheumatoid factor, were associated with BMD in the lumbar spine, a frequent pain site.
When you’re screening the general population, what’s the likelihood that those who are autoantibody positive will persist in testing positive in the future?
To gain perspective on the war on rheumatoid arthritis from the point of view of a researcher, I spoke with Dr. Dan Baker of Janssen Pharmaceutical.
Learn about the foundations of good research from one of our CJ summer interns.
What if there were a new treatment for your rheumatic condition that made you feel better, cost nothing, and only took 5 minutes per day?
An ArthritisPower Patient Governor attends rheumatology conference in Maui